Abstract
Conventional cancer treatments include cytotoxic chemotherapies and radiotherapy, which result in significant collateral toxicities. The goal for future cancer treatments is to leverage improved understanding of cancer biology mechanisms and thereby develop targeted drags that display exquisite tumor selectivity and avoid iatrogenic damage. In this review, we discuss the potential of tumor suppressor genes for development of cancer-selective drugs using the tumor suppressor p53 as an archetype.
Original language | English (US) |
---|---|
Pages (from-to) | 1959-1967 |
Number of pages | 9 |
Journal | Frontiers in Bioscience |
Volume | 13 |
Issue number | 5 |
DOIs | |
State | Published - 2008 |
Keywords
- Adenovirus
- Cancer
- Review
- Tumor suppressor
- p53
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- General Immunology and Microbiology